{"id":193,"date":"2019-10-17T22:24:59","date_gmt":"2019-10-18T02:24:59","guid":{"rendered":"https:\/\/opentextbc.ca\/nursingpharmacology\/chapter\/4-13-beta-1-antagonists\/"},"modified":"2023-01-10T17:19:26","modified_gmt":"2023-01-10T22:19:26","slug":"4-13-beta-1-antagonists","status":"publish","type":"chapter","link":"https:\/\/opentextbc.ca\/nursingpharmacology\/chapter\/4-13-beta-1-antagonists\/","title":{"raw":"4.13 Beta-1 Antagonists","rendered":"4.13 Beta-1 Antagonists"},"content":{"raw":"Metoprolol is a selective Beta-1 antagonist.\r\n\r\nMechanism of Action:<\/strong> Metoprolol primarily blocks Beta-1 receptors in the heart, causing decreased heart rate and decreased blood pressure. However, higher doses can also block Beta-2 receptors in the lungs, causing bronchoconstriction.\r\n\r\nIndications for Use:<\/strong>\u00a0 Metoprolol is commonly used to treat high blood pressure, chest pain due to poor blood flow to the heart, as an early intervention during a myocardial infarction (MI), and in several heart conditions involving an abnormally fast heart rate.\r\n\r\nNursing Considerations Across the Lifespan:\u00a0<\/strong>Beta-1 antagonists can be given to pediatric and older adult clients, but doses should be individualized based on client response.\r\n\r\nDo not crush extended-release (ER) formulations. Always check client's apical pulse rate before giving drug. Withhold the drug and call the prescriber immediately if the heart rate is slower than 60 beats\/minute, unless other parameters are provided. In diabetic clients, monitor glucose level closely because the drug masks common signs and symptoms of hypoglycemia. The most serious potential adverse effects are shortness of breath, bradycardia, and worsening heart failure. Other adverse effects include fatigue, dizziness, depression, insomnia, nightmares, gastrointestinal upset, erectile dysfunction, dyspnea, and wheezing.\r\n\r\nSafety Warning<\/strong>: When stopping therapy, the dosage should be tapered over 1 to 2 weeks because abrupt discontinuation may cause chest pain or myocardial infarction (MI).\r\n\r\nPatient Teaching & Education:\u00a0<\/strong>Patients should be instructed to take the medication as prescribed.\u00a0 They should be advised that abrupt cessation of medication therapy may result in life-threatening cardiac arrhythmias.\u00a0 Patients should also be taught how to self-check pulse and blood pressure to assess the effectiveness of medication therapy.\u00a0 Additionally, they should be cautioned against sudden changes in position due to orthostatic blood pressure changes.\u00a0 Patients may experience increased sensitivity to cold and should be cautioned to avoid caffeinated substances.[footnote]uCentral from Unbound Medicine. https:\/\/www.unboundmedicine.com\/ucentral<\/a>[\/footnote]\r\n

Metoprolol Medication Card<\/h1>\r\nNow let's take a closer look at the medication card for metoprolol.[footnote]This work is a derivative of Daily Med<\/a> by U.S. National Library of Medicine<\/a> in the public domain<\/a>.[\/footnote][footnote]UpToDate (2021). Metoprolol<\/em>. https:\/\/www.uptodate.com\/contents\/search<\/a>[\/footnote] Because information about medication is constantly changing, nurses should always consult evidence-based resources to review current recommendations before administering specific medication.\r\n
\r\n

Medication Card 4.13.1: Metoprolol<\/h2>\r\n<\/header>\r\n
\r\n\r\nClass:<\/strong> Beta-1 Antagonist\r\n\r\nPrototypes:<\/strong> Metoprolol\r\n

Therapeutic Effects<\/h3>\r\n